• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>GlaxoSmithKline PLC ADR

GlaxoSmithKline PLC ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. HFF Closes $337.5 Million Sale of and Financing of GSK Global Vaccine Centre in Rockville, Maryland

    HFF Closes $337.5 Million Sale of and Financing of GSK Global Vaccine Centre in Rockville, Maryland

  2. Chi-Med appoints Industry Veteran Paul Carter to Board of Directors

    Chi-Med appoints Industry Veteran Paul Carter to Board of Directors

  3. UPDATE: Drug makers, auto stocks yank European stocks lower for first time in 3 days

    UPDATE: Drug makers, auto stocks yank European stocks lower for first time in 3 days

  4. LONDON MARKETS: FTSE 100 Logs 10th Day Of All-time Highs

    LONDON MARKETS: FTSE 100 Logs 10th Day Of All-time Highs

  5. UPDATE: FTSE 100 logs 10th day of all-time highs

    UPDATE: FTSE 100 logs 10th day of all-time highs

  6. EUROPE MARKETS: Drug Makers Struggle, Pulling European Markets Lower

    EUROPE MARKETS: Drug Makers Struggle, Pulling European Markets Lower

  7. UPDATE: Drug makers struggle, pulling European markets lower

    UPDATE: Drug makers struggle, pulling European markets lower

  8. Launch of New Drugs to Impact Positively on the Infectious and Rare Diseases Market: Technavio

    Launch of New Drugs to Impact Positively on the Infectious and Rare Diseases Market: Technavio

  9. Avoid Medicare Advantage Plans

    GlaxoSmithKline GSK reported solid second-quarter results on Wednesday that were largely in line with our expectations, and we don't anticipate any changes to our fair value estimate. Sales increased 10% from the prior year driven by strong sales of asthma medicine Advair, diabetes medicine ...

  10. Low-Cost Exposure to U.S. Healthcare Firms

    This ETF holds a swath of large- and mid-cap U.S. healthcare companies.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.